Efficacy, Safety & Tolerability of Agomelatine in the Treatment of Major

See also
Status	Clinical Trial	Phase
Completed	`NCT00316160` - Sexual Functioning Study With Antidepressants	Phase 4
Completed	`NCT05416957` - Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets	Phase 1
Active, not recruiting	`NCT03642964` - A Study in Patients With Major Depressive Disorder	Phase 2
Terminated	`NCT01111565` - Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)	Phase 3
Completed	`NCT01912196` - Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)	Phase 2
Completed	`NCT00958204` - Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression	Phase 3
Completed	`NCT00102492` - Study Of GW679769 In Major Depressive Disorder	Phase 2
Completed	`NCT02012218` - Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy	Phase 3
Completed	`NCT01477203` - Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders	Phase 4
Completed	`NCT00768430` - Optimization of IV Ketamine for Treatment Resistant Depression	Phase 2
Completed	`NCT00559299` - Patient Tolerability Study of GSK163090	Phase 1
Terminated	`NCT01123707` - To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)	Phase 3
Completed	`NCT04403373` - Effectiveness of Walking Exercise in Improving Depression in Older Adults With Major Depressive Disorder, A Pilot Study	N/A
Completed	`NCT05541302` - Retrospective TMS Therapy for Adults With MDD
Recruiting	`NCT06385405` - Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment	N/A
Completed	`NCT00330616` - Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan	Phase 2
Recruiting	`NCT03012724` - Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)	N/A
Not yet recruiting	`NCT02395263` - Comparison of Yuxintine With Placebo in Treatment of MDD	Phase 2
Completed	`NCT02380066` - Comparison of Anyu Peibo With Placebo in Treatment of MDD	Phase 2
Completed	`NCT01187407` - A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment	Phase 3

NCT number	NCT00411242
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	December 2006

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms